The global market for Chronic Obstructive Pulmonary Disorder was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Chronic obstructive pulmonary disease (COPD) is a type of obstructive lung disease characterized by long-term breathing problems and poor airflow. The main symptoms include shortness of breath and cough with sputum production. COPD is a progressive disease, meaning it typically worsens over time.

The growth of the global chronic obstructive pulmonary disease (COPD) market is expected to be fueled by a high number of new, more efficacious and convenient products entering the market and commanding a greater value compared to the therapies already existing in the market. Another major factor propelling the growth of the market is the introduction of novel innovations like ultrasonic nebulizers, which are superior to the existing jet nebulizers. The competitive environment is expected to intensify with an increase in product extensions, technological innovations, and an increase in the number of mergers and acquisitions. The market for COPD drugs shows potential opportunity in both developed and developing countries. Due to the effectiveness and advancements in technology, many companies are focusing and collaborating to develop innovative COPD drugs and treatments.

This report aims to provide a comprehensive presentation of the global market for Chronic Obstructive Pulmonary Disorder, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Obstructive Pulmonary Disorder.

The Chronic Obstructive Pulmonary Disorder market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Obstructive Pulmonary Disorder market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Obstructive Pulmonary Disorder companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Obstructive Pulmonary Disorder Market Report

Report Metric	Details
Report Name	Chronic Obstructive Pulmonary Disorder Market
Segment by Type	Short-Acting Bronchodilators Corticosteroids Methylxanthines Long-Acting Bronchodilators Phosphodiesterase-4 Inhibitors Others
Segment by Application	Hospitals Clinics Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	GSK, Pfizer, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Ario Pharma, Roche, Ache, Almirall, Aquinox Pharmaceuticals, Asmacure, Astellas Pharma
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Obstructive Pulmonary Disorder company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Obstructive Pulmonary Disorder Market report?

Ans: The main players in the Chronic Obstructive Pulmonary Disorder Market are GSK, Pfizer, Merck, Novartis, AstraZeneca, Boehringer Ingelheim, Teva Pharmaceuticals, Ario Pharma, Roche, Ache, Almirall, Aquinox Pharmaceuticals, Asmacure, Astellas Pharma

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disorder Market report?

Ans: The Applications covered in the Chronic Obstructive Pulmonary Disorder Market report are Hospitals, Clinics, Others

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disorder Market report?

Ans: The Types covered in the Chronic Obstructive Pulmonary Disorder Market report are Short-Acting Bronchodilators, Corticosteroids, Methylxanthines, Long-Acting Bronchodilators, Phosphodiesterase-4 Inhibitors, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Short-Acting Bronchodilators

1.2.3 Corticosteroids

1.2.4 Methylxanthines

1.2.5 Long-Acting Bronchodilators

1.2.6 Phosphodiesterase-4 Inhibitors

1.2.7 Others

1.3 Market by Application

1.3.1 Global Chronic Obstructive Pulmonary Disorder Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Obstructive Pulmonary Disorder Market Perspective (2020-2031)

2.2 Global Chronic Obstructive Pulmonary Disorder Growth Trends by Region

2.2.1 Global Chronic Obstructive Pulmonary Disorder Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Obstructive Pulmonary Disorder Historic Market Size by Region (2020-2025)

2.2.3 Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Region (2026-2031)

2.3 Chronic Obstructive Pulmonary Disorder Market Dynamics

2.3.1 Chronic Obstructive Pulmonary Disorder Industry Trends

2.3.2 Chronic Obstructive Pulmonary Disorder Market Drivers

2.3.3 Chronic Obstructive Pulmonary Disorder Market Challenges

2.3.4 Chronic Obstructive Pulmonary Disorder Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Obstructive Pulmonary Disorder Players by Revenue

3.1.1 Global Top Chronic Obstructive Pulmonary Disorder Players by Revenue (2020-2025)

3.1.2 Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Obstructive Pulmonary Disorder Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Obstructive Pulmonary Disorder Revenue

3.4 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio

3.4.1 Global Chronic Obstructive Pulmonary Disorder Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disorder Revenue in 2024

3.5 Global Key Players of Chronic Obstructive Pulmonary Disorder Head office and Area Served

3.6 Global Key Players of Chronic Obstructive Pulmonary Disorder, Product and Application

3.7 Global Key Players of Chronic Obstructive Pulmonary Disorder, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Obstructive Pulmonary Disorder Breakdown Data by Type

4.1 Global Chronic Obstructive Pulmonary Disorder Historic Market Size by Type (2020-2025)

4.2 Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Type (2026-2031)

5 Chronic Obstructive Pulmonary Disorder Breakdown Data by Application

5.1 Global Chronic Obstructive Pulmonary Disorder Historic Market Size by Application (2020-2025)

5.2 Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Obstructive Pulmonary Disorder Market Size (2020-2031)

6.2 North America Chronic Obstructive Pulmonary Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025)

6.4 North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Obstructive Pulmonary Disorder Market Size (2020-2031)

7.2 Europe Chronic Obstructive Pulmonary Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025)

7.4 Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size (2020-2031)

8.2 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Obstructive Pulmonary Disorder Market Size (2020-2031)

9.2 Latin America Chronic Obstructive Pulmonary Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025)

9.4 Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size (2020-2031)

10.2 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GSK

11.1.1 GSK Company Details

11.1.2 GSK Business Overview

11.1.3 GSK Chronic Obstructive Pulmonary Disorder Introduction

11.1.4 GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.1.5 GSK Recent Development

11.2 Pfizer

11.2.1 Pfizer Company Details

11.2.2 Pfizer Business Overview

11.2.3 Pfizer Chronic Obstructive Pulmonary Disorder Introduction

11.2.4 Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.2.5 Pfizer Recent Development

11.3 Merck

11.3.1 Merck Company Details

11.3.2 Merck Business Overview

11.3.3 Merck Chronic Obstructive Pulmonary Disorder Introduction

11.3.4 Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.3.5 Merck Recent Development

11.4 Novartis

11.4.1 Novartis Company Details

11.4.2 Novartis Business Overview

11.4.3 Novartis Chronic Obstructive Pulmonary Disorder Introduction

11.4.4 Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.4.5 Novartis Recent Development

11.5 AstraZeneca

11.5.1 AstraZeneca Company Details

11.5.2 AstraZeneca Business Overview

11.5.3 AstraZeneca Chronic Obstructive Pulmonary Disorder Introduction

11.5.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.5.5 AstraZeneca Recent Development

11.6 Boehringer Ingelheim

11.6.1 Boehringer Ingelheim Company Details

11.6.2 Boehringer Ingelheim Business Overview

11.6.3 Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Introduction

11.6.4 Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.6.5 Boehringer Ingelheim Recent Development

11.7 Teva Pharmaceuticals

11.7.1 Teva Pharmaceuticals Company Details

11.7.2 Teva Pharmaceuticals Business Overview

11.7.3 Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Introduction

11.7.4 Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.7.5 Teva Pharmaceuticals Recent Development

11.8 Ario Pharma

11.8.1 Ario Pharma Company Details

11.8.2 Ario Pharma Business Overview

11.8.3 Ario Pharma Chronic Obstructive Pulmonary Disorder Introduction

11.8.4 Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.8.5 Ario Pharma Recent Development

11.9 Roche

11.9.1 Roche Company Details

11.9.2 Roche Business Overview

11.9.3 Roche Chronic Obstructive Pulmonary Disorder Introduction

11.9.4 Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.9.5 Roche Recent Development

11.10 Ache

11.10.1 Ache Company Details

11.10.2 Ache Business Overview

11.10.3 Ache Chronic Obstructive Pulmonary Disorder Introduction

11.10.4 Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.10.5 Ache Recent Development

11.11 Almirall

11.11.1 Almirall Company Details

11.11.2 Almirall Business Overview

11.11.3 Almirall Chronic Obstructive Pulmonary Disorder Introduction

11.11.4 Almirall Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.11.5 Almirall Recent Development

11.12 Aquinox Pharmaceuticals

11.12.1 Aquinox Pharmaceuticals Company Details

11.12.2 Aquinox Pharmaceuticals Business Overview

11.12.3 Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Introduction

11.12.4 Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.12.5 Aquinox Pharmaceuticals Recent Development

11.13 Asmacure

11.13.1 Asmacure Company Details

11.13.2 Asmacure Business Overview

11.13.3 Asmacure Chronic Obstructive Pulmonary Disorder Introduction

11.13.4 Asmacure Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.13.5 Asmacure Recent Development

11.14 Astellas Pharma

11.14.1 Astellas Pharma Company Details

11.14.2 Astellas Pharma Business Overview

11.14.3 Astellas Pharma Chronic Obstructive Pulmonary Disorder Introduction

11.14.4 Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

11.14.5 Astellas Pharma Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Aquinox Pharmaceuticals

ASMACURE

Astellas Pharma

List of Tables

Table 1. Global Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Short-Acting Bronchodilators

Table 3. Key Players of Corticosteroids

Table 4. Key Players of Methylxanthines

Table 5. Key Players of Long-Acting Bronchodilators

Table 6. Key Players of Phosphodiesterase-4 Inhibitors

Table 7. Key Players of Others

Table 8. Global Chronic Obstructive Pulmonary Disorder Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 9. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 10. Global Chronic Obstructive Pulmonary Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 11. Global Chronic Obstructive Pulmonary Disorder Market Share by Region (2020-2025)

Table 12. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 13. Global Chronic Obstructive Pulmonary Disorder Market Share by Region (2026-2031)

Table 14. Chronic Obstructive Pulmonary Disorder Market Trends

Table 15. Chronic Obstructive Pulmonary Disorder Market Drivers

Table 16. Chronic Obstructive Pulmonary Disorder Market Challenges

Table 17. Chronic Obstructive Pulmonary Disorder Market Restraints

Table 18. Global Chronic Obstructive Pulmonary Disorder Revenue by Players (2020-2025) & (US$ Million)

Table 19. Global Chronic Obstructive Pulmonary Disorder Market Share by Players (2020-2025)

Table 20. Global Top Chronic Obstructive Pulmonary Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder as of 2024)

Table 21. Ranking of Global Top Chronic Obstructive Pulmonary Disorder Companies by Revenue (US$ Million) in 2024

Table 22. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disorder Revenue (CR5 and HHI) & (2020-2025)

Table 23. Global Key Players of Chronic Obstructive Pulmonary Disorder, Headquarters and Area Served

Table 24. Global Key Players of Chronic Obstructive Pulmonary Disorder, Product and Application

Table 25. Global Key Players of Chronic Obstructive Pulmonary Disorder, Date of Enter into This Industry

Table 26. Mergers & Acquisitions, Expansion Plans

Table 27. Global Chronic Obstructive Pulmonary Disorder Market Size by Type (2020-2025) & (US$ Million)

Table 28. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type (2020-2025)

Table 29. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 30. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Type (2026-2031)

Table 31. Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2020-2025) & (US$ Million)

Table 32. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application (2020-2025)

Table 33. Global Chronic Obstructive Pulmonary Disorder Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 34. Global Chronic Obstructive Pulmonary Disorder Revenue Market Share by Application (2026-2031)

Table 35. North America Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 37. North America Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 38. Europe Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 39. Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 40. Europe Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 41. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 42. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2020-2025) & (US$ Million)

Table 43. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size by Region (2026-2031) & (US$ Million)

Table 44. Latin America Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 46. Latin America Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 47. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 48. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2020-2025) & (US$ Million)

Table 49. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size by Country (2026-2031) & (US$ Million)

Table 50. GSK Company Details

Table 51. GSK Business Overview

Table 52. GSK Chronic Obstructive Pulmonary Disorder Product

Table 53. GSK Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 54. GSK Recent Development

Table 55. Pfizer Company Details

Table 56. Pfizer Business Overview

Table 57. Pfizer Chronic Obstructive Pulmonary Disorder Product

Table 58. Pfizer Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 59. Pfizer Recent Development

Table 60. Merck Company Details

Table 61. Merck Business Overview

Table 62. Merck Chronic Obstructive Pulmonary Disorder Product

Table 63. Merck Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 64. Merck Recent Development

Table 65. Novartis Company Details

Table 66. Novartis Business Overview

Table 67. Novartis Chronic Obstructive Pulmonary Disorder Product

Table 68. Novartis Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 69. Novartis Recent Development

Table 70. AstraZeneca Company Details

Table 71. AstraZeneca Business Overview

Table 72. AstraZeneca Chronic Obstructive Pulmonary Disorder Product

Table 73. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 74. AstraZeneca Recent Development

Table 75. Boehringer Ingelheim Company Details

Table 76. Boehringer Ingelheim Business Overview

Table 77. Boehringer Ingelheim Chronic Obstructive Pulmonary Disorder Product

Table 78. Boehringer Ingelheim Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 79. Boehringer Ingelheim Recent Development

Table 80. Teva Pharmaceuticals Company Details

Table 81. Teva Pharmaceuticals Business Overview

Table 82. Teva Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product

Table 83. Teva Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 84. Teva Pharmaceuticals Recent Development

Table 85. Ario Pharma Company Details

Table 86. Ario Pharma Business Overview

Table 87. Ario Pharma Chronic Obstructive Pulmonary Disorder Product

Table 88. Ario Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 89. Ario Pharma Recent Development

Table 90. Roche Company Details

Table 91. Roche Business Overview

Table 92. Roche Chronic Obstructive Pulmonary Disorder Product

Table 93. Roche Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 94. Roche Recent Development

Table 95. Ache Company Details

Table 96. Ache Business Overview

Table 97. Ache Chronic Obstructive Pulmonary Disorder Product

Table 98. Ache Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 99. Ache Recent Development

Table 100. Almirall Company Details

Table 101. Almirall Business Overview

Table 102. Almirall Chronic Obstructive Pulmonary Disorder Product

Table 103. Almirall Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 104. Almirall Recent Development

Table 105. Aquinox Pharmaceuticals Company Details

Table 106. Aquinox Pharmaceuticals Business Overview

Table 107. Aquinox Pharmaceuticals Chronic Obstructive Pulmonary Disorder Product

Table 108. Aquinox Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 109. Aquinox Pharmaceuticals Recent Development

Table 110. Asmacure Company Details

Table 111. Asmacure Business Overview

Table 112. Asmacure Chronic Obstructive Pulmonary Disorder Product

Table 113. Asmacure Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 114. Asmacure Recent Development

Table 115. Astellas Pharma Company Details

Table 116. Astellas Pharma Business Overview

Table 117. Astellas Pharma Chronic Obstructive Pulmonary Disorder Product

Table 118. Astellas Pharma Revenue in Chronic Obstructive Pulmonary Disorder Business (2020-2025) & (US$ Million)

Table 119. Astellas Pharma Recent Development

Table 120. Research Programs/Design for This Report

Table 121. Key Data Information from Secondary Sources

Table 122. Key Data Information from Primary Sources

Table 123. Authors List of This Report

List of Figures

Figure 1. Chronic Obstructive Pulmonary Disorder Picture

Figure 2. Global Chronic Obstructive Pulmonary Disorder Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Obstructive Pulmonary Disorder Market Share by Type: 2024 VS 2031

Figure 4. Short-Acting Bronchodilators Features

Figure 5. Corticosteroids Features

Figure 6. Methylxanthines Features

Figure 7. Long-Acting Bronchodilators Features

Figure 8. Phosphodiesterase-4 Inhibitors Features

Figure 9. Others Features

Figure 10. Global Chronic Obstructive Pulmonary Disorder Market Size by Application (2020-2031) & (US$ Million)

Figure 11. Global Chronic Obstructive Pulmonary Disorder Market Share by Application: 2024 VS 2031

Figure 12. Hospitals Case Studies

Figure 13. Clinics Case Studies

Figure 14. Others Case Studies

Figure 15. Chronic Obstructive Pulmonary Disorder Report Years Considered

Figure 16. Global Chronic Obstructive Pulmonary Disorder Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 17. Global Chronic Obstructive Pulmonary Disorder Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 18. Global Chronic Obstructive Pulmonary Disorder Market Share by Region: 2024 VS 2031

Figure 19. Global Chronic Obstructive Pulmonary Disorder Market Share by Players in 2024

Figure 20. Global Top Chronic Obstructive Pulmonary Disorder Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disorder as of 2024)

Figure 21. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disorder Revenue in 2024

Figure 22. North America Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. North America Chronic Obstructive Pulmonary Disorder Market Share by Country (2020-2031)

Figure 24. United States Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Canada Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. Europe Chronic Obstructive Pulmonary Disorder Market Share by Country (2020-2031)

Figure 28. Germany Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. France Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. U.K. Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Italy Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Russia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Nordic Countries Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. Asia-Pacific Chronic Obstructive Pulmonary Disorder Market Share by Region (2020-2031)

Figure 36. China Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. Japan Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. South Korea Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Southeast Asia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. India Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Australia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Latin America Chronic Obstructive Pulmonary Disorder Market Share by Country (2020-2031)

Figure 44. Mexico Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Brazil Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. Middle East & Africa Chronic Obstructive Pulmonary Disorder Market Share by Country (2020-2031)

Figure 48. Turkey Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. UAE Chronic Obstructive Pulmonary Disorder Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 51. GSK Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 52. Pfizer Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 53. Merck Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 54. Novartis Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 55. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 56. Boehringer Ingelheim Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 57. Teva Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 58. Ario Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 59. Roche Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 60. Ache Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 61. Almirall Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 62. Aquinox Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 63. Asmacure Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 64. Astellas Pharma Revenue Growth Rate in Chronic Obstructive Pulmonary Disorder Business (2020-2025)

Figure 65. Bottom-up and Top-down Approaches for This Report

Figure 66. Data Triangulation

Figure 67. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

COPD Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

COPD Medication Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Chronic Obstructive Pulmonary Diseases Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global COPD Inhaler Market Research Report 2025

Global Asthma and COPD Devices Market Insights Forecast to 2030

Global COPD Drugs Market Research Report 2024

Global Chronic Obstructive Pulmonary Disease COPD Treatment Market Insights Forecast to 2030

Global Emphysema Treatment Medication Market Research Report 2024

Global COPD and Asthma Devices Market Research Report 2024

Asthma and COPD Drug Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Emphysema Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Dyspnea Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Lung Pulmonary Airway Disease Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Asthma Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Genetic COPD Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Digital Health Solutions For Chronic Conditions Market Research Report 2024

Global Interstitial Lung Disease ILD Market Research Report 2024

Chronic Lung Diseases Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Chronic Respiratory Diseases Treatment Market Insights Forecast to 2030

120 Pages

Type: Report

Code: QYRE-Auto-19Y19888

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Oxygen Inhaler Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-11D3386

Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Chronic Obstructive Pulmonary Disorder (COPD) Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26D2937

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Bronchiectasis Treatment Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-18E6080

Mon Sep 08 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Chronic Obstructive Pulmonary Disorder Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-30A1621

Global Chronic Obstructive Pulmonary Disorder Market Research Report 2025

FEATURED COMPANIES

Chronic Obstructive Pulmonary Disorder Market

Scope of Chronic Obstructive Pulmonary Disorder Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Chronic Obstructive Pulmonary Disorder Market report?

What are the Application segmentation covered in the Chronic Obstructive Pulmonary Disorder Market report?

What are the Type segmentation covered in the Chronic Obstructive Pulmonary Disorder Market report?

FEATURED COMPANIES

RELATED REPORTS